Treatment of Adult Men with High-risk Biochemical Recurrent Non-metastatic Hormone-sensitive Prostate Cancer as Monotherapy or in Combination with Androgen Deprivation Therapy, Who Are Unsuitable for Salvage Radiotherapy

The medicines shown here belong to the Prostate Health category and are used for managing Treatment of Adult Men with High-risk Biochemical Recurrent Non-metastatic Hormone-sensitive Prostate Cancer as Monotherapy or in Combination with Androgen Deprivation Therapy, Who Are Unsuitable for Salvage Radiotherapy. Products containing Enzalutamide feature in this group.